(Q51621780)

English

Primer extension based quantitative polymerase chain reaction reveals consistent differences in the methylation status of the MGMT promoter in diffusely infiltrating gliomas (WHO grade II-IV) of adults.

scientific article published on 22 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

Primer extension based quantitative polymerase chain reaction reveals consistent differences in the methylation status of the MGMT promoter in diffusely infiltrating gliomas (WHO grade II-IV) of adults. (English)

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

author name string

Erik Vassella

1

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

Istvan Vajtai

2

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

Nora Bandi

3

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

Marlene Arnold

4

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

Verena Kocher

5

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

Luigi Mariani

6

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

publication date

22 December 2010

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

104

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

1

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

293-303

1 reference

Europe PubMed Central

8 April 2018

http://europepmc.org/abstract/MED/21181234

https://scigraph.springernature.com/pub.10.1007/s11060-010-0490-4

0 references

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Recent developments in the use of chemotherapy in brain tumours.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Brain tumors: molecular biology and targeted therapies

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Chemoradiotherapy in malignant glioma: standard of care and future directions

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

The power and the promise of DNA methylation markers

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

SiDCoN: a tool to aid scoring of DNA copy number changes in SNP chip data

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE).

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Cross-talk between aging and cancer: the epigenetic language

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine-methyltransferase

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0490-4

21 January 2018

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21181234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21181234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21181234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MGMT analysis at DNA, RNA and protein levels in glioblastoma tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21181234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21181234

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-010-0490-4

1 reference

https://api.fatcat.wiki/v0/release/2zbg7d46wjccpmrrqhmsnyukpi

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_2zbg7d46wjccpmrrqhmsnyukpi

1 reference

https://api.fatcat.wiki/v0/release/2zbg7d46wjccpmrrqhmsnyukpi

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/2zbg7d46wjccpmrrqhmsnyukpi

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51621780&oldid=1801752567"